More importantly, enforced PLK1 expression markedly restored AKT activity in plumbagin-treated ESCC cells, suggesting that PLK1 is a critical mediator of plumbagin-induced AKT inactivation. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.